Weifang, Shandong, China Related Funds
| Fund Name | Location |
| 208 Seed Ventures | Columbia, Missouri, United States |
| Adidas | Bayern, Germany, Herzogenaurach |
| Beishang Capital | Beijing, Beijing, China |
| Ceniarth | California, San Francisco, United States |
| CR-CP Life Science Fund | China, Hong Kong, Hong Kong Island |
| Happy Elements | Beijing, Beijing, China |
| Hengqin Financial Investment | - |
| HgCapital Trust plc | England, London, United Kingdom |
| Huigu Chuang Tou | Changning, China, Shanghai |
| National Association of Broadcasters | - |
| PINOVA Capital | Bayern, Germany, Munich |
| Shenzhenshi Jiafa Venture Capital | China, Guangdong, Shenzhen |
| Sorenson Development | - |
| Trihill Capital | - |
| Wakestream Ventures | Grand Rapids, Michigan, United States |
| Wintrust Ventures | Illinois, Rosamond, United States |
| Yiyi | China, Chongqing, Chongqing Shi |
| Yongda Zichan | China, Hongkou District |
| Zicom Holdings | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Manteia | $17M | 18 Jan 2024 | Xiamen, China | ||
Huichuang Medical | $15M | 31 Oct 2023 | Dongcheng District, Beijing, China | ||
Fitow | $15M | 04 Sep 2023 | Guangdong, Tianjin, China | ||
Milestone | $15M | 22 Aug 2023 | Zhangjiang, Hunan, China | ||
Cobot | 25 Jul 2022 | Wuhan, Hubei, China | |||
Enzymaster | $7M | 30 Sep 2020 | Yinzhou District, Zhejiang, China | ||
Iristar | $3M | 08 Jan 2020 | Hexi, Tianjin |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Manteia | $17M | 18 Jan 2024 | Xiamen, China | ||
Huichuang Medical | $15M | 31 Oct 2023 | Dongcheng District, Beijing, China | ||
Fitow | $15M | 04 Sep 2023 | Guangdong, Tianjin, China | ||
Milestone | $15M | 22 Aug 2023 | Zhangjiang, Hunan, China | ||
Cobot | 25 Jul 2022 | Wuhan, Hubei, China | |||
Enzymaster | $7M | 30 Sep 2020 | Yinzhou District, Zhejiang, China | ||
Iristar | $3M | 08 Jan 2020 | Hexi, Tianjin |
